254 related articles for article (PubMed ID: 12601017)
1. COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Alousis NS; Kelly DJ; Gilbert RE
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):974-9. PubMed ID: 12601017
[TBL] [Abstract][Full Text] [Related]
2. Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase-2 and vascular endothelial growth factor expression.
Liu NN; Sun YZ; Zhao N; Chen L
Clin Exp Ophthalmol; 2015 Jul; 43(5):458-65. PubMed ID: 25472856
[TBL] [Abstract][Full Text] [Related]
3. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
Pierce EA; Foley ED; Smith LE
Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081
[TBL] [Abstract][Full Text] [Related]
4. The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity.
Rabinowitz R; Katz G; Rosner M; Pri-Chen S; Spierer A
Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):843-8. PubMed ID: 18343940
[TBL] [Abstract][Full Text] [Related]
5. Increased retinal neovascularization in Fas ligand-deficient mice.
Davies MH; Eubanks JP; Powers MR
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3202-10. PubMed ID: 12824272
[TBL] [Abstract][Full Text] [Related]
6. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity.
Gu X; Samuel S; El-Shabrawey M; Caldwell RB; Bartoli M; Marcus DM; Brooks SE
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):496-502. PubMed ID: 11818396
[TBL] [Abstract][Full Text] [Related]
7. Adenosine A1 Receptors Selectively Modulate Oxygen-Induced Retinopathy at the Hyperoxic and Hypoxic Phases by Distinct Cellular Mechanisms.
Zhang S; Li H; Li B; Zhong D; Gu X; Tang L; Wang Y; Wang C; Zhou R; Li Y; He Y; Chen M; Huo Y; Liu XL; Chen JF
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8108-19. PubMed ID: 26720463
[TBL] [Abstract][Full Text] [Related]
8. Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice.
Brooks SE; Gu X; Samuel S; Marcus DM; Bartoli M; Huang PL; Caldwell RB
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):222-8. PubMed ID: 11133872
[TBL] [Abstract][Full Text] [Related]
9. Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy.
Higgins RD; Yu K; Sanders RJ; Nandgaonkar BN; Rotschild T; Rifkin DB
Curr Eye Res; 1999 Jan; 18(1):20-7. PubMed ID: 10075199
[TBL] [Abstract][Full Text] [Related]
10. Genetic inactivation of the adenosine A2A receptor attenuates pathologic but not developmental angiogenesis in the mouse retina.
Liu XL; Zhou R; Pan QQ; Jia XL; Gao WN; Wu J; Lin J; Chen JF
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6625-32. PubMed ID: 20610844
[TBL] [Abstract][Full Text] [Related]
11. [Suppression of retinal angiogenesis by quercetin in a rodent model of retinopathy of prematurity].
Chen Y; Li F; Meng X; Li X
Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(14):1113-5. PubMed ID: 26081216
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.
Brafman A; Mett I; Shafir M; Gottlieb H; Damari G; Gozlan-Kelner S; Vishnevskia-Dai V; Skaliter R; Einat P; Faerman A; Feinstein E; Shoshani T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.
Barnett JM; McCollum GW; Fowler JA; Duan JJ; Kay JD; Liu RQ; Bingaman DP; Penn JS
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):907-15. PubMed ID: 17251494
[TBL] [Abstract][Full Text] [Related]
14. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
15. The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy.
Stitt AW; McKenna D; Simpson DA; Gardiner TA; Harriott P; Archer DB; Nelson J
Am J Pathol; 1998 May; 152(5):1359-65. PubMed ID: 9588904
[TBL] [Abstract][Full Text] [Related]
16. Phosphomannopentaose sulfate (PI-88) suppresses angiogenesis by downregulating heparanase and vascular endothelial growth factor in an oxygen-induced retinal neovascularization animal model.
Liang XJ; Yuan L; Hu J; Yu HH; Li T; Lin SF; Tang SB
Mol Vis; 2012; 18():1649-57. PubMed ID: 22773903
[TBL] [Abstract][Full Text] [Related]
17. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of retinal neovascularization in a rat model of oxygen fluctuations-induced retinopathy].
Liu X; Wang W; Wang AR; Ning Q; Luo XP
Zhonghua Er Ke Za Zhi; 2007 Jan; 45(1):7-13. PubMed ID: 17349140
[TBL] [Abstract][Full Text] [Related]
19. Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR).
Scott A; Powner MB; Fruttiger M
Exp Eye Res; 2014 Mar; 120():55-60. PubMed ID: 24418725
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Liu N; Chen L; Cai N
Int J Clin Exp Pathol; 2015; 8(5):4990-8. PubMed ID: 26191192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
